Subset Derivation of T-cell Acute Lymphoblastic Leukemia in Man
Overview
Affiliations
Normal human peripheral blood T cells can be characterized as belonging to either the TH+2 or TH-2 T-cell subset. Approximately 20% of T cells are TH+2, whereas 80% are TH-2 utilizing specific heteroantisera. To determine shether human T-cell acute lymphoblastic leukemia (T-ALL) cells belong to one or another T-cell subset, cell surface phenotyping was performed on tumor populations from 25 patients with T-ALL. Tmuor cells from these 25 individuals were either TH+1 or TH-2, but not both. 5 of 25 patients had TH+2 T-ALL cells. These TH+2 tumor populations were found exclusively in children and often without an accompanying thymic mass. TH-2 T-ALL, in contrast, occurred in both children and adults and was almost always associated with thymic enlargement. Although children with TH+2 T-ALL had as high or higher peripheral blast counts on presentation than their TH-2 T-ALL counterparts, overall survival was greater for the TH+2 group (greater than 36 mo) than the TH-2 group (less than 12 mo). These studies demonstrate that T-cell leukemias in man arise from distinct T-cell subsets and that cell surface characterization of T-cell malignancies may provide useful clinical data related to prognosis.
Current management of childhood acute lymphocytic leukemia.
Ekert H Indian J Pediatr. 1981; 48(393):491-9.
PMID: 7035349 DOI: 10.1007/BF02822298.
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Bast Jr R, Feeney M, Lazarus H, Nadler L, Colvin R, Knapp R J Clin Invest. 1981; 68(5):1331-7.
PMID: 7028788 PMC: 370929. DOI: 10.1172/jci110380.
Immunologic diagnosis and monitoring of human acute leukemias: a review.
Maheu M, Baker M, Falk J, Taub R Am J Pathol. 1981; 103(1):139-58.
PMID: 7013493 PMC: 1903806.
Childhood acute lymphocytic leukemia: progress and problems in treatment.
Bowman W Can Med Assoc J. 1981; 124(2):129-42.
PMID: 7006781 PMC: 1705168.
The T lymphoblastic malignancies.
Nadler L, Reinherz E, Schlossman S Cancer Chemother Pharmacol. 1980; 4(1):11-5.
PMID: 6988098 DOI: 10.1007/BF00255452.